- Phentermine Hydrochloride, a prescription medication used for short-term weight loss, is increasingly important due to the global rise in obesity and overweight conditions
- The rising prevalence of obesity, combined with greater awareness of medical weight-loss solutions and expanded healthcare access, is driving the demand for Phentermine Hydrochloride globally
- North America dominated the phentermine hydrochloride market with 39.7% share in 2024, reflecting high obesity rates, comprehensive insurance coverage, robust healthcare infrastructure, and significant use of prescription weight-loss drugs
- Asia-Pacific is expected to be the fastest growing region in the phentermine hydrochloride market during the forecast period, driven by increased healthcare spending, greater access to generics, rising obesity awareness, and rising incomes in countries such as China, India, and Japan
- Tablets dominated the phentermine hydrochloride market with a market share of 60.6% in 2024, supported by patient preference, convenience, and the availability of generic tablet formulations
